The expression of ICOSL is noteworthy in light of a recent study which found that naïve B cells are able to reactivate effector memory CD4+ T cells from SLE and RA patients in an ICOSL-dependent manner even in the absence of T cell receptor triggering (205). This evidence concerns the gene CD4 and rheumatoid arthritis.